<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32766931</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>The capacity to consent to treatment in amyotrophic lateral sclerosis: a preliminary report.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>226</EndPage><MedlinePgn>219-226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10136-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Facing the relentless worsening of their condition, ALS patients are required to make decisions on treatments and end-of-life care. A cognitive impairment showed to be a negative prognostic factor in ALS patients, perhaps affecting the ability to make informed decisions. Notwithstanding its crucial role, the capacity to consent to treatment (CCT) has never been evaluated in these patients.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the CCT in an ALS cohort in comparison to a control group, and to study the effects of demographic and clinical variables on this high-level cognitive function.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">102 ALS patients and 106 healthy controls (HC) were enrolled. CCT was assessed using the MacArthur Competence Assessment Tool for Treatment (MAC-CAT-T) and the performance was classified into the three CCT outcomes (full credit, partial credit, no credit). Cognitive and psychological variables were assessed by MMSE, phonemic fluencies, Frontal System Behavioural Scale (FrSBe), and ALS Depression Inventory (ADI). Clinical and demographic variables were analyzed as possible predictors of the MAC-CAT-T outcomes. After a 1-year follow-up, CCT and neuropsychological assessments were repeated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most ALS patients (i.e., from 75 to 83% according to the different sub-items) retain full CCT. However, a subpopulation of the ALS patients showed a reduced CCT with respect to the HC. Age, education, phonemic fluency, and depression appeared related to the CCT outcomes. After 1 year, only the reasoning items worsened.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is a preliminary report suggesting that the large majority of ALS patients can retain full ability to choose between treatment options. However, demographic and neuropsychological variables may affect CCT, pointing to the need for special attention to the consent disclosure in this disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spataro</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8910-3131</Identifier><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi Bonino Pulejo, Palermo, Italy. rossellaspataro@libero.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Bella</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ALS Clinical Research Center, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>841116</GrantID><Agency>H2020 Marie Sk&#x142;odowska-Curie Actions</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Decision-making</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32766931</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10136-7</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10136-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Charcot JM (1874) De la scl&#xe9;rose lat&#xe9;rale amyotrophique. Prog Med 2:325&#x2013;327</Citation></Reference><Reference><Citation>Goldstein LH, Abrahams S (2013) Change in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 12:368&#x2013;380</Citation><ArticleIdList><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson ED, Hesse JH, Rose KD et al (2005) Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 65:719&#x2013;725</Citation></Reference><Reference><Citation>Gordon PH, Goetz RR, Rabkin JG et al (2010) A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler 11:312&#x2013;320</Citation><ArticleIdList><ArticleId IdType="pubmed">20225929</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P et al (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:1263&#x2013;1269</Citation><ArticleIdList><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Ilardi A, Cammarosano S et al (2012) Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 78:1085&#x2013;1089</Citation><ArticleIdList><ArticleId IdType="pubmed">22442427</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelbaum PS, Grisso P (1988) Assessing patients&#x2019; capacity to consent to treatment. N Engl J Med 319:1635&#x2013;1638</Citation><ArticleIdList><ArticleId IdType="pubmed">3200278</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisso T, Appelbaum PS (1998) Assessing competence to consent to treatment. A guide for physicians and other health professionals. Oxford University Press, New York</Citation></Reference><Reference><Citation>Marson DC, Schmitt F, Ingram KK et al (1994) Determining the competency of Alzheimer&#x2019;s patients to consent to treatment and research. Alzheimer Dis Assoc Disord 8(suppl 4):5&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">7695856</ArticleId></ArticleIdList></Reference><Reference><Citation>Marson DC, Chatterjee A, Ingram KK et al (1996) Toward a neurologic model of competency: cognitive predictors of capacity to consent in Alzheimer&#x2019;s disease using three different legal standards. Neurology 46:666&#x2013;672</Citation><ArticleIdList><ArticleId IdType="pubmed">8618664</ArticleId></ArticleIdList></Reference><Reference><Citation>Huthwaite JS, Martin RC, Griffith R et al (2006) Declining medical decision-making capacity in mild AD: a two-year longitudinal study. Behav Sci Law 24:453&#x2013;463</Citation><ArticleIdList><ArticleId IdType="pubmed">16883623</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonkwo OC, Griffith HR, Copeland JN et al (2008) Medical decision-making capacity in mild cognitive impairment. Neurology 71:1474&#x2013;1480</Citation><ArticleIdList><ArticleId IdType="pubmed">18981368</ArticleId><ArticleId IdType="pmc">2676965</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith HR, Dymek MP, Atchison P et al (2005) Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment. Neurology 65:483&#x2013;485</Citation><ArticleIdList><ArticleId IdType="pubmed">16087924</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin RC, Okonkwo OC, Hill J et al (2008) Medical decision-making capacity in cognitively impaired Parkinson&#x2019;s disease patients without dementia. Mov Disord 23(13):1867&#x2013;1874</Citation><ArticleIdList><ArticleId IdType="pubmed">18759361</ArticleId><ArticleId IdType="pmc">2579319</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlawish J, Cary M, Moelter ST et al (2013) Cognitive impairment and PD patients&#x2019; capacity to consent to research. Neurology 81:801&#x2013;807</Citation><ArticleIdList><ArticleId IdType="pubmed">23892706</ArticleId><ArticleId IdType="pmc">3908465</ArticleId></ArticleIdList></Reference><Reference><Citation>Triebel KL, Martin RC, Novack TA et al (2012) Treatment consent capacity in patients with traumatic brain injury across a range of injury severity. Neurology 78:1472&#x2013;1478</Citation><ArticleIdList><ArticleId IdType="pubmed">22496195</ArticleId><ArticleId IdType="pmc">3345615</ArticleId></ArticleIdList></Reference><Reference><Citation>Triebel KL, Martin RC, Novack TA et al (2014) Recovery over 6 months of medical decision-making capacity after traumatic brain injury. Arch Phys Med Rehabil 95:2296&#x2013;2303</Citation><ArticleIdList><ArticleId IdType="pubmed">25152169</ArticleId><ArticleId IdType="pmc">4652592</ArticleId></ArticleIdList></Reference><Reference><Citation>Triebel KL, Martin RC, Nabors LB et al (2009) Medical decision-making capacity in patients with malignant glioma. Neurology 73:2086&#x2013;2092</Citation><ArticleIdList><ArticleId IdType="pubmed">20018637</ArticleId><ArticleId IdType="pmc">2833103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SYH, Marson DC (2014) Assessing decisional capacity in patients with brain tumours. Neurology 83:482&#x2013;483</Citation><ArticleIdList><ArticleId IdType="pubmed">24991036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerrigan S, Erridge S, Liaquat I et al (2014) Mental incapacity in patients undergoing neuro-oncologic treatment. Neurology 83:537&#x2013;541</Citation><ArticleIdList><ArticleId IdType="pubmed">24991034</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1:293&#x2013;299</Citation></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546&#x2013;1554</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH et al (2017) Amyotrophic lateral Sclerosis&#x2014;frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotr Lat Scler Frontotemp Degen 18:153&#x2013;174</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III)0. J Neurol Sci 169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezak MD (ed) (1995) Neuropsychological assessment, 3rd edn. Oxford University Press, Oxford, pp 544&#x2013;550</Citation></Reference><Reference><Citation>Abrahams S, Leigh PN, Harvey A et al (2000) Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 38:734&#x2013;747</Citation><ArticleIdList><ArticleId IdType="pubmed">10689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Murphy J, Langmore S et al (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094&#x2013;1097</Citation><ArticleIdList><ArticleId IdType="pubmed">12682312</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace J, Malloy P (2001) The frontal systems behavior scale manual. Psychological Assessment Resources, Odessa</Citation></Reference><Reference><Citation>Hammer EM, H&#xe4;cker S, Hautzinger M et al (2008) Validity of the ALS-Depression-Inventory (ADI-12)&#x2014;a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Dis 109:213&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pubmed">18262283</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR (1975) &#x201c;Mini-mental state:&#x201d; a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189&#x2013;198</Citation></Reference><Reference><Citation>Measso G, Caravenzan F, Zappal&#xe0; G et al (1993) The Mini-Mental State Examination: normative study of a random Italian population. Dev Neuropsychol 9:77&#x2013;85</Citation></Reference><Reference><Citation>Grisso T, Appelbaum P (1997) The MacCAT-T: a clinical tool to assess patients&#x2019; capacities to make treatment decisions. Psychiatr Serv 48:1415&#x2013;1419</Citation><ArticleIdList><ArticleId IdType="pubmed">9355168</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisso T, Appelbaum P (2000) Il consenso alle cure. Guida alla valutazione per medici e altri operatori sanitari. Centro Scientifico Editore, Torino</Citation></Reference><Reference><Citation>Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83:102&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K et al (2018) ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91:e1370&#x2013;e1380</Citation><ArticleIdList><ArticleId IdType="pubmed">30209236</ArticleId><ArticleId IdType="pmc">6177274</ArticleId></ArticleIdList></Reference><Reference><Citation>Benbrika S, Desgranges B, Eustache F et al (2019) Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review. Front Neurosci 13:951e1-e22</Citation></Reference><Reference><Citation>Sturman ED (2005) The capacity to consent to treatment and research: A review of standardised assessment tools. Clin Psychol Rev 25:954&#x2013;974</Citation><ArticleIdList><ArticleId IdType="pubmed">15964671</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Bono V, Marchese S et al (2012) Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis. J Neurol Sci 323:66&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pubmed">22989611</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, La Bella V (2012) Ethical issues: invasive ventilation in amyotrophic lateral sclerosis. BMJ Support Palliat Care 2:85&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">24654044</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6:994&#x2013;1003</Citation><ArticleIdList><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassimiro L, Fuentes D, Nitrini R et al (2017) Decision-making in cognitively Illiterate and low-educated older women: results on the Iowa Gambling Task. Arch Clin Neuropsychol 32(1):71&#x2013;80. https://doi.org/10.1093/arclin/acw080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acw080</ArticleId><ArticleId IdType="pubmed">27680089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tymula A, Rosenberg BL, Rudermanb L et al (2013) Like cognitive function, decision making across the life span shows profound age-related changes. PNAS 42:17143&#x2013;17148</Citation></Reference><Reference><Citation>Whiteside DM, Kealey T, Semla M et al (2016) Verbal fluency: language or executive function measure? Appl Neuropsychol Adult 23:29&#x2013;34.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2015.1004574</ArticleId><ArticleId IdType="pubmed">26111011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>